NICOLE KLEIN: Open Payments
NPI 1407121544 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 94 payments from 27 companies in 2025. Trend: 2023 $1,250 · 2024 $1,797 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $275 |
| AstraZeneca Pharmaceuticals LP | 12 | $250 |
| Novo Nordisk Inc | 15 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $134 |
| Astellas Pharma US Inc | 4 | $86 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| PFIZER INC. | 3 | $62 |
| Merck Sharp & Dohme LLC | 4 | $60 |
| ViiV Healthcare Company | 3 | $58 |
Products named: UBRELVY, JARDIANCE, Wegovy, Veozah, Kerendia, SHINGRIX, Ozempic, APRETUDE.
Industry payments across CO — which companies pay providers there.
